NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

I was surprised some on the FDA review board already weighed in on Geron's application before the actual review. Thought that was a no-no??

>>The regulator said more treatment-emergent adverse events, serious adverse events and events leading to dose modification were observed in the imetelstat group compared to placebo in a phase 3 study in certain patients with myelodysplastic syndrome.